Correlation Between Tissue Regenix and Pressure Technologies

Can any of the company-specific risk be diversified away by investing in both Tissue Regenix and Pressure Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tissue Regenix and Pressure Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tissue Regenix Group and Pressure Technologies Plc, you can compare the effects of market volatilities on Tissue Regenix and Pressure Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tissue Regenix with a short position of Pressure Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tissue Regenix and Pressure Technologies.

Diversification Opportunities for Tissue Regenix and Pressure Technologies

0.43

Correlation Coefficient

Tissue Regenix  Pressure Technologies

Very weak diversification

The 3 months correlation between Tissue and Pressure is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Tissue Regenix Group and Pressure Technologies Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pressure Technologies Plc and Tissue Regenix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tissue Regenix Group are associated (or correlated) with Pressure Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pressure Technologies Plc has no effect on the direction of Tissue Regenix i.e., Tissue Regenix and Pressure Technologies go up and down completely randomly.

Pair Corralation between Tissue Regenix and Pressure Technologies

Assuming the 90 days trading horizon Tissue Regenix is expected to generate 1.44 times less return on investment than Pressure Technologies. But when comparing it to its historical volatility, Tissue Regenix Group is 1.13 times less risky than Pressure Technologies. It trades about 0.09 of its potential returns per unit of risk. Pressure Technologies Plc is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  3,250  in Pressure Technologies Plc on October 23, 2024 and sell it today you would earn a total of  400.00  from holding Pressure Technologies Plc or generate 12.31% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Tissue Regenix Group  vs.  Pressure Technologies Plc

Tissue Regenix Group

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Tissue Regenix Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Tissue Regenix may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pressure Technologies Plc

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Pressure Technologies Plc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Pressure Technologies unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Tissue Regenix and Pressure Technologies

The main advantage of trading using opposite Tissue Regenix and Pressure Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tissue Regenix position performs unexpectedly, Pressure Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pressure Technologies will offset losses from the drop in Pressure Technologies' long position.

The idea behind Tissue Regenix Group and Pressure Technologies Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.